| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |